Beta-2 adrenergic receptor genetic polymorphisms and asthma
Author:
- 1 December 2009
- journal article
- review article
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 34 (6) , 631-643
Abstract
Beta-2-Adrenergic receptors (beta(2)AR) participate in the physiologic responses of the lung, including bronchodilation and bronchoprotection, through mechanisms such as mucociliary clearance, fluid accumulation and mediator release from mast cells and basophils. Thus, these receptors may also play an important role in the pathophysiology of asthma. The gene encoding beta(2)AR (ADRB2) is extremely polymorphic, and studies of this gene improves our understanding of asthma and possibly lead to new methods to prevent, diagnose and treat it. This review summarizes results from various studies on the possible relationship of ADRB2 polymorphisms to asthma and asthma-related phenotypes, including bronchodilator responses to inhaled beta(2)-agonists. At present, it appears that, for asthma, ADRB2 polymorphisms are not aetiologically involved. However, they might affect disease severity and clinical response to both acute and chronic administration of beta(2)-agonists. The development is that by assessing the ADRB2 genotype, it might be possible to predict the clinical course of asthma as well as responsiveness to chronic administration of beta(2)-agonists. Carefully, performed and adequately powered clinical trials continue to be important for achieving those goals.Keywords
This publication has 108 references indexed in Scilit:
- ARG1 Is a Novel Bronchodilator Response GeneAmerican Journal of Respiratory and Critical Care Medicine, 2008
- A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of β2-adrenergic receptorsPharmacogenetics and Genomics, 2008
- Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthmaPharmacogenetics and Genomics, 2008
- The safety and effects of the beta-blocker, nadolol, in mild asthma: An open-label pilot studyPulmonary Pharmacology & Therapeutics, 2008
- Influence of β2‐adrenoceptor gene polymorphisms on β2‐adrenoceptor‐mediated responses in human lung mast cellsBritish Journal of Pharmacology, 2007
- Sequence, Haplotype, and Association Analysis of ADRβ2 in a Multiethnic Asthma Case-Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Arginine-16 2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterolThorax, 2006
- Association between β2-adrenoceptor polymorphisms and asthma diagnosis among Mexican adultsJournal of Allergy and Clinical Immunology, 2003
- Asthma control during long term treatment with regular inhaled salbutamol and salmeterolThorax, 1998
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996